BOLOGNA ed altri: "Modifiche alla legge 11 gennaio 2018, n. 3, in materia di indipendenza e trasparenza nelle sperimentazioni cliniche dei farmaci" (1318)

This procedure proposes changes to existing Italian law regarding the independence and transparency of clinical drug trials. It aims to ensure that trials are conducted impartially and that results are reported openly. The changes affect pharmaceutical companies, research institutions, and patients participating in or relying on clinical trial data. It seeks to enhance public trust in drug safety and efficacy.